Cutia Therapeutics Enrolls Final Patient in Phase II Trial of Weight Loss Drug
Cutia Therapeutics Enrolls Final Patient in Phase II Trial of Weight Loss Drug
Cutia Therapeutics在减肥药物II期试验中招募了最后一位患者
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册
资讯热榜
更新时间